
Glenmark Life Sciences Limited has informed the Exchange regarding a press release dated July 25, 2024, titled "Press Release on the Unaudited Financial Results of the Company for the First Quarter ended June 30, 2024".
Filed with NSE ·

Glenmark Life Sciences Limited has informed the Exchange regarding a press release dated July 25, 2024, titled "Press Release on the Unaudited Financial Results of the Company for the First Quarter ended June 30, 2024".
6ix hasn’t read this filing yet.
Alivus Life Sciences Ltd on 6ix
Follow Alivus Life Sciences into a list and get an email when it puts out news.
Follow Alivus Life Sciences